Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation

References

• European Heart Rhythm Association, European Association for Cardio-Thoracic SurgeryCammAJKirchhofPLipGYGuidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)Eur Heart J201031192369242920802247
   PubMed Web of Science ®Google Scholar
• WolfPAAbbottRDKannelWBAtrial fibrillation as an independent risk factor for stroke: the Framingham StudyStroke19912289839881866765
   PubMed Web of Science ®Google Scholar
• PenadoSCanoMAchaOHernándezJLRianchoJAAtrial fibrillation as a risk factor for stroke recurrenceAm J Med2003114320621012637135
   PubMed Web of Science ®Google Scholar
• StewartSHartCLHoleDJMcMurrayJJA population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley studyAm J Med2002113535936412401529
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• PatelMRMahaffeyKWGargJROCKET AF InvestigatorsRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
   PubMed Web of Science ®Google Scholar
• EastonJDLopesRDBahitMCARISTOTLE Committees and InvestigatorsApixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trialLancet Neurol201211650351122572202
   PubMed Web of Science ®Google Scholar
• GiuglianoRPRuffCTBraunwaldEENGAGE AF-TIMI 48 InvestigatorsEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
   PubMed Web of Science ®Google Scholar
• MonzBUConnollySJKorhonenMNoackHPooleyJAssessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-studyInt J Cardiol201316832540254723664436
   PubMed Web of Science ®Google Scholar
• AlegretJMViñolasXAriasMANew oral anticoagulants vs vitamin K antagonists: benefits for health-related quality of life in patients with atrial fibrillationInt J Med Sci201411768068424843316
   PubMed Web of Science ®Google Scholar
• HASFibrillation Atriale HAS 2014 Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-05/guide_pds_fibrillation_atriale_vf.pdfAccessed September 12, 2017
   Google Scholar
• ChevalierJde PouvourvilleGValuing EQ-5D using time trade-off in FranceEur J Health Econ2013141576621935715
   PubMed Web of Science ®Google Scholar
• PrinsMHMarrelACaritaPMultinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the “Perception of Anticoagulant Treatment Questionnaire” (PACT-Q)Health Qual Life Outcomes20097919196486
   PubMed Web of Science ®Google Scholar
• MoriskyDEAngAKrousel-WoodMWardHPredictive validity of a medication adherence measure in a patient settingJ Clin Hyper2008105348354
   PubMed Web of Science ®Google Scholar
• PrinsMHGuilleminIGiletHScoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q)Health Qual Life Outcomes200973019348685
   PubMed Web of Science ®Google Scholar
• MoriskyDEDiMatteoMRImproving the measurement of self-reported medication nonadherence: Final responseJ Clin Epidem201164258263
   Web of Science ®Google Scholar
• MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
   PubMed Web of Science ®Google Scholar
• Krousel-WoodMAIslamTWebberLSReRSMoriskyDEMuntnerPNew medication adherence scale versus pharmacy fill rates in seniors with hypertensionAm J Manag Care2009151596619146365
   PubMed Web of Science ®Google Scholar
• WangYKongMCKoYPsychometric properties of the 8-item Mor-isky Medication Adherence Scale in patients taking warfarinThromb Haemost2012108478979522836920
   PubMed Web of Science ®Google Scholar
• CammAJAmarencoPHaasSXANTUS InvestigatorsXANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillationEur Heart J201637141145115326330425
   PubMed Web of Science ®Google Scholar
• KakkarAKMuellerIBassandJPGARFIELD Registry InvestigatorsRisk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registryPLoS One201385e6347923704912
   PubMed Web of Science ®Google Scholar
• HuismanMVRothmanKJPaquetteMGLORIA-AF InvestigatorsAntithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation: the GLORIA-AF registry, phase IIAm J Med20151281213061313.e126239094
   PubMed Web of Science ®Google Scholar
• Le HeuzeyJYAmmentorpBDariusHDifferences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registryThromb Haemost2014111583384124651882
   PubMed Web of Science ®Google Scholar
• RuffCTGiuglianoRPBraunwaldEComparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsLancet2014383992195596224315724
   PubMed Web of Science ®Google Scholar
• BrüggenjürgenBSchliephackeTDariusHTreatment satisfaction in patients with atrial fibrillation on new oral anticoagulants as assessed with PACT-Q2 at baseline and 12-month follow-up: prefer in Af registryValue Health2014177A497
   Web of Science ®Google Scholar
• ApostolakisSLaneDAGuoYBullerHLipGYPerformance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) studyJ Am Coll Cardiol201260986186722858389
   PubMed Web of Science ®Google Scholar
• NieuwlaatRCapucciACammAJEuropean Heart Survey InvestigatorsAtrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial FibrillationEur Heart J200526222422243416204266
   PubMed Web of Science ®Google Scholar
• LiardFLe HeuzeyJYAliotEMaboPLeenhardtAAtrial fibrillation and anticoagulation: general practitioner, cardiologist and patient’s points of viewPresse Méd2013427–8e259e270 French23465299
   PubMedGoogle Scholar
• MarvigCLVerhoefTIde BoerAEU-PACT consortiumQuality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulantsThromb Res20151361697525956287
   PubMed Web of Science ®Google Scholar
• CastellucciLAShawJvan der SalmKSelf-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scaleThromb Res2015136472773126272305
   PubMed Web of Science ®Google Scholar
• HorstmannSRizosTSaribasMEfthymiouERauchGVeltkampRCognitive impairment is not a predictor of failure to adhere to anticoagulation of stroke patients with atrial fibrillationCerebrovasc Dis2015395–632533125966900
   PubMed Web of Science ®Google Scholar
• KneelandPPFangMCCurrent issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolismPatient Prefer Adherence20104516020361065
   PubMed Web of Science ®Google Scholar
• LégaréFWittemanHOShared decision making: examining key elements and barriers to adoption into routine clinical practiceHealth Aff (Millwood)201332227628423381520
   PubMed Web of Science ®Google Scholar
• PalacioAMKirolosITamarizLPatients values and preferences when choosing anticoagulantsPatient Prefer Adherence2015913313825653506
   PubMed Web of Science ®Google Scholar
• BoomMSBerghuisEMNieuwkerkPTPinedoSBüllerHRWhen do patients prefer a direct oral anticoagulant over a vitamin K antagonist?Neth J Med201573836837226478546
   PubMed Web of Science ®Google Scholar